TABLE 2.
Diagnoses and Diagnostic Yield.
| Forceps biopsy | Cryobiopsy | Overall Diagnostic yield | |
|---|---|---|---|
| Malignant (n=158) | |||
| Adenocarcinoma | 74/113 | 92/113 | 102/113 |
| MIA | 0/2 | 0/2 | 0/2 |
| Squamous cell carcinoma | 18/22 | 21/22 | 22/22 |
| NSCLC | 3/6 | 4/6 | 5/6 |
| Small cell carcinoma | 2/2 | 2/2 | 2/2 |
| Metastasis | 5/8 | 7/8 | 7/8 |
| Pleomorphic carcinoma with AD | 0/1 | 0/1 | 0/1 |
| Sarcomatoid carcinoma | 0/1 | 1/1 | 1/1 |
| Lymphoma | 1/1 | 1/1 | 1/1 |
| Malignancy | 0/1 | 0/1 | 0/1 |
| Typical carcinoid | 0/1 | 1/1 | 1/1 |
| 103/158 (65.2%) | 129/158 (81.6%) | 141/158 (89.2%) | |
| Benign (n=41) | |||
| Tuberculosis | 2/3 | 3/3 | 3/3 |
| NTM | 1/4 | 4/4 | 4/4 |
| Organizing pneumonia | 7/13 | 12/13 | 13/13 |
| Lung abscess/pneumonia | 2/2 | 2/2 | 2/2 |
| Legionella pneumonia | 0/1 | 1/1 | 1/1 |
| Toxocariasis | 1/1 | 1/1 | 1/1 |
| Paragonimiasis | 0/1 | 1/1 | 1/1 |
| Benign disease, NOS | 14/16 | 15/16 | 16/16 |
| 27/41 (65.9) | 39/41 (95.1%) | 41/41 (100%) | |
Data are presented as number (%).
AD indicates adenocarcinoma; MIA, minimally invasive adenocarcinoma; NSCLC, non-small cell lung cancer; NOS, not otherwise specified; NTM, nontuberculous mycobacterial lung disease.